United Therapeutics Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Okay. Welcome to the afternoon sessions of the second day of the BofA Virtual Vegas Health Care Conference. I'm Geoff Meacham, I'm the senior biopharma analyst here at BofA. I have also Jason Zemansky from my team on as well. And we're really excited to have United Therapeutics present today with slides. And speaking on behalf of United, we have James Edgemond, the CFO. James, are you there?
I am, Geoff. Thank you for the introduction. I'd like to thank you, yes. And I'd like to thank you and Jason and BofA Securities for the opportunity to present United Therapeutics at your Virtual Health Care Conference this afternoon. Good afternoon, everyone, and thank you for listening to our webcast presentation. I'm joined today on this webcast by my colleague, Mr. Dewey Steadman, United Therapeutics Head of Investor Relations. We've organized our presentation today into 3 sections, which consists of an overview
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |